1. General Consideration....................................................................... ............................................ 1 i. Tumor Vaccines 7 ii. Tumor Markers 9 2. Cancer Chemotherapy.................................................................................................................... 13 3. Cancer Pain..................................................................................................................................... 40 4. Oncological Emergencies.............................................................................................................. 43 5. Paraneoplastic Syndromes................................................................................................................................... ,.......... 49 6. Aids- related Malignancies............................................................................ 58 7. Radiotherapy............................................................................................... 73 8. Breast Diseases and Conditions.................................................................... 80 9. Endocrine Tumors........ ............................................................................... 94 i. Parathyroid Diseases 94 ii. Thyroid Diseases and Conditions 99 iii. Adrenal Gland Diseases 114 10. Brain Tumors............................................................................................. 118 11. Hematological Malignancies........................................................................ 121 12. Lung Cancer.............................................................................................. 172 13. Skin Tumors................................. ............................................................. 179 14. Bone Tumors.............................................................................................. 194 15. Hepatocellular Carcinoma ...................................................................... 208 16. Tumors of Genitourinary Tract..................................................................... 228 17. Pediatric Oncology........................................................................................................................ 276 18. Intraocular Melanoma 347 |